|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:APP-SEC63 (FusionGDB2 ID:HG351TG11231) |
Fusion Gene Summary for APP-SEC63 |
Fusion gene summary |
Fusion gene information | Fusion gene name: APP-SEC63 | Fusion gene ID: hg351tg11231 | Hgene | Tgene | Gene symbol | APP | SEC63 | Gene ID | 351 | 11231 |
Gene name | amyloid beta precursor protein | SEC63 homolog, protein translocation regulator | |
Synonyms | AAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2|preA4 | DNAJC23|ERdj2|PCLD2|PRO2507|SEC63L | |
Cytomap | ('APP')('SEC63') 21q21.3 | 6q21 | |
Type of gene | protein-coding | protein-coding | |
Description | amyloid-beta precursor proteinalzheimer disease amyloid proteinamyloid beta (A4) precursor proteinamyloid beta A4 proteinamyloid precursor proteinbeta-amyloid peptidebeta-amyloid peptide(1-40)beta-amyloid peptide(1-42)beta-amyloid precursor protei | translocation protein SEC63 homologSEC63 protein translocation regulatorSEC63-like protein | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000346798, ENST00000348990, ENST00000354192, ENST00000357903, ENST00000358918, ENST00000359726, ENST00000439274, ENST00000440126, ENST00000448388, ENST00000474136, | ||
Fusion gene scores | * DoF score | 31 X 25 X 12=9300 | 38 X 14 X 15=7980 |
# samples | 33 | 39 | |
** MAII score | log2(33/9300*10)=-4.81669278663694 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(39/7980*10)=-4.3548427173601 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: APP [Title/Abstract] AND SEC63 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | APP(27252862)-SEC63(108214782), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | APP-SEC63 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. APP-SEC63 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. APP-SEC63 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. APP-SEC63 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. APP-SEC63 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | APP | GO:0001934 | positive regulation of protein phosphorylation | 11404397 |
Hgene | APP | GO:0008285 | negative regulation of cell proliferation | 22944668 |
Hgene | APP | GO:1905606 | regulation of presynapse assembly | 19726636 |
Fusion gene breakpoints across APP (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SEC63 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | THCA | TCGA-DJ-A13S-01A | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
Top |
Fusion Gene ORF analysis for APP-SEC63 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000346798 | ENST00000460009 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
5CDS-intron | ENST00000348990 | ENST00000460009 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
5CDS-intron | ENST00000354192 | ENST00000460009 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
5CDS-intron | ENST00000357903 | ENST00000460009 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
5CDS-intron | ENST00000358918 | ENST00000460009 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
5CDS-intron | ENST00000359726 | ENST00000460009 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
Frame-shift | ENST00000346798 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
Frame-shift | ENST00000348990 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
Frame-shift | ENST00000354192 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
Frame-shift | ENST00000357903 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
In-frame | ENST00000358918 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
In-frame | ENST00000359726 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
intron-3CDS | ENST00000439274 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
intron-3CDS | ENST00000440126 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
intron-3CDS | ENST00000448388 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
intron-3CDS | ENST00000474136 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
intron-intron | ENST00000439274 | ENST00000460009 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
intron-intron | ENST00000440126 | ENST00000460009 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
intron-intron | ENST00000448388 | ENST00000460009 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
intron-intron | ENST00000474136 | ENST00000460009 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000358918 | APP | chr21 | 27252862 | - | ENST00000369002 | SEC63 | chr6 | 108214782 | - | 8232 | 3578 | 200 | 2458 | 752 |
ENST00000359726 | APP | chr21 | 27252862 | - | ENST00000369002 | SEC63 | chr6 | 108214782 | - | 8118 | 3464 | 200 | 2344 | 714 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000358918 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - | 0.000420623 | 0.99957937 |
ENST00000359726 | ENST00000369002 | APP | chr21 | 27252862 | - | SEC63 | chr6 | 108214782 | - | 0.000469041 | 0.99953103 |
Top |
Fusion Genomic Features for APP-SEC63 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Top |
Fusion Protein Features for APP-SEC63 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr21:27252862/chr6:108214782) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 230_260 | 1144 | 771.0 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 274_280 | 1144 | 771.0 | Compositional bias | Note=Poly-Thr |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 230_260 | 1069 | 696.0 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 274_280 | 1069 | 696.0 | Compositional bias | Note=Poly-Thr |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 230_260 | 1013 | 640.0 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 274_280 | 1013 | 640.0 | Compositional bias | Note=Poly-Thr |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 230_260 | 1125 | 752.0 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 274_280 | 1125 | 752.0 | Compositional bias | Note=Poly-Thr |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 230_260 | 1126 | 753.0 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 274_280 | 1126 | 753.0 | Compositional bias | Note=Poly-Thr |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 230_260 | 1088 | 715.0 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 274_280 | 1088 | 715.0 | Compositional bias | Note=Poly-Thr |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 28_189 | 1144 | 771.0 | Domain | E1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 374_565 | 1144 | 771.0 | Domain | E2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 28_189 | 1069 | 696.0 | Domain | E1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 374_565 | 1069 | 696.0 | Domain | E2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 28_189 | 1013 | 640.0 | Domain | E1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 374_565 | 1013 | 640.0 | Domain | E2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 28_189 | 1125 | 752.0 | Domain | E1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 374_565 | 1125 | 752.0 | Domain | E2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 28_189 | 1126 | 753.0 | Domain | E1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 374_565 | 1126 | 753.0 | Domain | E2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 28_189 | 1088 | 715.0 | Domain | E1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 374_565 | 1088 | 715.0 | Domain | E2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 344_365 | 1144 | 771.0 | Motif | OX-2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 724_734 | 1144 | 771.0 | Motif | Note=Basolateral sorting signal |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 344_365 | 1069 | 696.0 | Motif | OX-2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 724_734 | 1069 | 696.0 | Motif | Note=Basolateral sorting signal |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 344_365 | 1013 | 640.0 | Motif | OX-2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 724_734 | 1013 | 640.0 | Motif | Note=Basolateral sorting signal |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 344_365 | 1125 | 752.0 | Motif | OX-2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 724_734 | 1125 | 752.0 | Motif | Note=Basolateral sorting signal |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 344_365 | 1126 | 753.0 | Motif | OX-2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 724_734 | 1126 | 753.0 | Motif | Note=Basolateral sorting signal |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 344_365 | 1088 | 715.0 | Motif | OX-2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 724_734 | 1088 | 715.0 | Motif | Note=Basolateral sorting signal |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 131_189 | 1144 | 771.0 | Region | CuBD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 181_188 | 1144 | 771.0 | Region | Note=Zinc-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 28_123 | 1144 | 771.0 | Region | GFLD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 391_423 | 1144 | 771.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 491_522 | 1144 | 771.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 523_540 | 1144 | 771.0 | Region | Collagen-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 96_110 | 1144 | 771.0 | Region | Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 131_189 | 1069 | 696.0 | Region | CuBD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 181_188 | 1069 | 696.0 | Region | Note=Zinc-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 28_123 | 1069 | 696.0 | Region | GFLD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 391_423 | 1069 | 696.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 491_522 | 1069 | 696.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 523_540 | 1069 | 696.0 | Region | Collagen-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 96_110 | 1069 | 696.0 | Region | Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 131_189 | 1013 | 640.0 | Region | CuBD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 181_188 | 1013 | 640.0 | Region | Note=Zinc-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 28_123 | 1013 | 640.0 | Region | GFLD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 391_423 | 1013 | 640.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 491_522 | 1013 | 640.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 523_540 | 1013 | 640.0 | Region | Collagen-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 96_110 | 1013 | 640.0 | Region | Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 131_189 | 1125 | 752.0 | Region | CuBD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 181_188 | 1125 | 752.0 | Region | Note=Zinc-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 28_123 | 1125 | 752.0 | Region | GFLD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 391_423 | 1125 | 752.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 491_522 | 1125 | 752.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 523_540 | 1125 | 752.0 | Region | Collagen-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 96_110 | 1125 | 752.0 | Region | Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 131_189 | 1126 | 753.0 | Region | CuBD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 181_188 | 1126 | 753.0 | Region | Note=Zinc-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 28_123 | 1126 | 753.0 | Region | GFLD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 391_423 | 1126 | 753.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 491_522 | 1126 | 753.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 523_540 | 1126 | 753.0 | Region | Collagen-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 96_110 | 1126 | 753.0 | Region | Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 131_189 | 1088 | 715.0 | Region | CuBD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 181_188 | 1088 | 715.0 | Region | Note=Zinc-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 28_123 | 1088 | 715.0 | Region | GFLD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 391_423 | 1088 | 715.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 491_522 | 1088 | 715.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 523_540 | 1088 | 715.0 | Region | Collagen-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 96_110 | 1088 | 715.0 | Region | Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 18_701 | 1144 | 771.0 | Topological domain | Extracellular |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 723_770 | 1144 | 771.0 | Topological domain | Cytoplasmic |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 18_701 | 1069 | 696.0 | Topological domain | Extracellular |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 723_770 | 1069 | 696.0 | Topological domain | Cytoplasmic |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 18_701 | 1013 | 640.0 | Topological domain | Extracellular |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 723_770 | 1013 | 640.0 | Topological domain | Cytoplasmic |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 18_701 | 1125 | 752.0 | Topological domain | Extracellular |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 723_770 | 1125 | 752.0 | Topological domain | Cytoplasmic |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 18_701 | 1126 | 753.0 | Topological domain | Extracellular |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 723_770 | 1126 | 753.0 | Topological domain | Cytoplasmic |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 18_701 | 1088 | 715.0 | Topological domain | Extracellular |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 723_770 | 1088 | 715.0 | Topological domain | Cytoplasmic |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 702_722 | 1144 | 771.0 | Transmembrane | Helical |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 702_722 | 1069 | 696.0 | Transmembrane | Helical |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 702_722 | 1013 | 640.0 | Transmembrane | Helical |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 702_722 | 1125 | 752.0 | Transmembrane | Helical |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 702_722 | 1126 | 753.0 | Transmembrane | Helical |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 702_722 | 1088 | 715.0 | Transmembrane | Helical |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 597_635 | 0 | 761.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 734_760 | 0 | 761.0 | Compositional bias | Note=Asp/Glu-rich (highly acidic) | |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 104_165 | 0 | 761.0 | Domain | J | |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 197_541 | 0 | 761.0 | Domain | Note=SEC63 1 | |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 637_714 | 0 | 761.0 | Domain | Note=SEC63 2 | |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 1_14 | 0 | 761.0 | Topological domain | Lumenal | |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 210_760 | 0 | 761.0 | Topological domain | Cytoplasmic | |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 36_69 | 0 | 761.0 | Topological domain | Cytoplasmic | |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 91_188 | 0 | 761.0 | Topological domain | Lumenal | |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 15_35 | 0 | 761.0 | Transmembrane | Helical | |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 189_209 | 0 | 761.0 | Transmembrane | Helical | |
Tgene | SEC63 | chr21:27252862 | chr6:108214782 | ENST00000369002 | 0 | 21 | 70_90 | 0 | 761.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 230_260 | 0 | 747.0 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 274_280 | 0 | 747.0 | Compositional bias | Note=Poly-Thr |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 28_189 | 0 | 747.0 | Domain | E1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 374_565 | 0 | 747.0 | Domain | E2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 344_365 | 0 | 747.0 | Motif | OX-2 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 724_734 | 0 | 747.0 | Motif | Note=Basolateral sorting signal |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 131_189 | 0 | 747.0 | Region | CuBD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 181_188 | 0 | 747.0 | Region | Note=Zinc-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 28_123 | 0 | 747.0 | Region | GFLD subdomain |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 391_423 | 0 | 747.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 491_522 | 0 | 747.0 | Region | Note=Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 523_540 | 0 | 747.0 | Region | Collagen-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 96_110 | 0 | 747.0 | Region | Heparin-binding |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 18_701 | 0 | 747.0 | Topological domain | Extracellular |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 723_770 | 0 | 747.0 | Topological domain | Cytoplasmic |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 702_722 | 0 | 747.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for APP-SEC63 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>5705_5705_1_APP-SEC63_APP_chr21_27252862_ENST00000358918_SEC63_chr6_108214782_ENST00000369002_length(transcript)=8232nt_BP=3578nt GGATCAGCTGACTCGCCTGGCTCTGAGCCCCGCCGCCGCGCTCGGGCTCCGTCAGTTTCCTCGGCAGCGGTAGGCGAGAGCACGCGGAGG AGCGTGCGCGGGGGCCCCGGGAGACGGCGGCGGTGGCGGCGCGGGCAGAGCAAGGACGCGGCGGATCCCACTCGCACAGCAGCGCACTCG GTGCCCCGCGCAGGGTCGCGATGCTGCCCGGTTTGGCACTGCTCCTGCTGGCCGCCTGGACGGCTCGGGCGCTGGAGGTACCCACTGATG GTAATGCTGGCCTGCTGGCTGAACCCCAGATTGCCATGTTCTGTGGCAGACTGAACATGCACATGAATGTCCAGAATGGGAAGTGGGATT CAGATCCATCAGGGACCAAAACCTGCATTGATACCAAGGAAGGCATCCTGCAGTATTGCCAAGAAGTCTACCCTGAACTGCAGATCACCA ATGTGGTAGAAGCCAACCAACCAGTGACCATCCAGAACTGGTGCAAGCGGGGCCGCAAGCAGTGCAAGACCCATCCCCACTTTGTGATTC CCTACCGCTGCTTAGTTGGTGAGTTTGTAAGTGATGCCCTTCTCGTTCCTGACAAGTGCAAATTCTTACACCAGGAGAGGATGGATGTTT GCGAAACTCATCTTCACTGGCACACCGTCGCCAAAGAGACATGCAGTGAGAAGAGTACCAACTTGCATGACTACGGCATGTTGCTGCCCT GCGGAATTGACAAGTTCCGAGGGGTAGAGTTTGTGTGTTGCCCACTGGCTGAAGAAAGTGACAATGTGGATTCTGCTGATGCGGAGGAGG ATGACTCGGATGTCTGGTGGGGCGGAGCAGACACAGACTATGCAGATGGGAGTGAAGACAAAGTAGTAGAAGTAGCAGAGGAGGAAGAAG TGGCTGAGGTGGAAGAAGAAGAAGCCGATGATGACGAGGACGATGAGGATGGTGATGAGGTAGAGGAAGAGGCTGAGGAACCCTACGAAG AAGCCACAGAGAGAACCACCAGCATTGCCACCACCACCACCACCACCACAGAGTCTGTGGAAGAGGTGGTTCGAGAGGTGTGCTCTGAAC AAGCCGAGACGGGGCCGTGCCGAGCAATGATCTCCCGCTGGTACTTTGATGTGACTGAAGGGAAGTGTGCCCCATTCTTTTACGGCGGAT GTGGCGGCAACCGGAACAACTTTGACACAGAAGAGTACTGCATGGCCGTGTGTGGCAGCGCCATGTCCCAAAGTTTACTCAAGACTACCC AGGAACCTCTTGCCCGAGATCCTGTTAAACTTCCTACAACAGCAGCCAGTACCCCTGATGCCGTTGACAAGTATCTCGAGACACCTGGGG ATGAGAATGAACATGCCCATTTCCAGAAAGCCAAAGAGAGGCTTGAGGCCAAGCACCGAGAGAGAATGTCCCAGGTCATGAGAGAATGGG AAGAGGCAGAACGTCAAGCAAAGAACTTGCCTAAAGCTGATAAGAAGGCAGTTATCCAGCATTTCCAGGAGAAAGTGGAATCTTTGGAAC AGGAAGCAGCCAACGAGAGACAGCAGCTGGTGGAGACACACATGGCCAGAGTGGAAGCCATGCTCAATGACCGCCGCCGCCTGGCCCTGG AGAACTACATCACCGCTCTGCAGGCTGTTCCTCCTCGGCCTCGTCACGTGTTCAATATGCTAAAGAAGTATGTCCGCGCAGAACAGAAGG ACAGACAGCACACCCTAAAGCATTTCGAGCATGTGCGCATGGTGGATCCCAAGAAAGCCGCTCAGATCCGGTCCCAGGTTATGACACACC TCCGTGTGATTTATGAGCGCATGAATCAGTCTCTCTCCCTGCTCTACAACGTGCCTGCAGTGGCCGAGGAGATTCAGGATGAAGTTGATG AGCTGCTTCAGAAAGAGCAAAACTATTCAGATGACGTCTTGGCCAACATGATTAGTGAACCAAGGATCAGTTACGGAAACGATGCTCTCA TGCCATCTTTGACCGAAACGAAAACCACCGTGGAGCTCCTTCCCGTGAATGGAGAGTTCAGCCTGGACGATCTCCAGCCGTGGCATTCTT TTGGGGCTGACTCTGTGCCAGCCAACACAGAAAACGAAGGTTCTGGGTTGACAAATATCAAGACGGAGGAGATCTCTGAAGTGAAGATGG ATGCAGAATTCCGACATGACTCAGGATATGAAGTTCATCATCAAAAATTGGTGTTCTTTGCAGAAGATGTGGGTTCAAACAAAGGTGCAA TCATTGGACTCATGGTGGGCGGTGTTGTCATAGCGACAGTGATCGTCATCACCTTGGTGATGCTGAAGAAGAAACAGTACACATCCATTC ATCATGGTGTGGTGGAGGTTGACGCCGCTGTCACCCCAGAGGAGCGCCACCTGTCCAAGATGCAGCAGAACGGCTACGAAAATCCAACCT ACAAGTTCTTTGAGCAGATGCAGAACTAGACCCCCGCCACAGCAGCCTCTGAAGTTGGACAGCAAAACCATTGCTTCACTACCCATCGGT GTCCATTTATAGAATAATGTGGGAAGAAACAAACCCGTTTTATGATTTACTCATTATCGCCTTTTGACAGCTGTGCTGTAACACAAGTAG ATGCCTGAACTTGAATTAATCCACACATCAGTAATGTATTCTATCTCTCTTTACATTTTGGTCTCTATACTACATTATTAATGGGTTTTG TGTACTGTAAAGAATTTAGCTGTATCAAACTAGTGCATGAATAGATTCTCTCCTGATTATTTATCACATAGCCCCTTAGCCAGTTGTATA TTATTCTTGTGGTTTGTGACCCAATTAAGTCCTACTTTACATATGCTTTAAGAATCGATGGGGGATGCTTCATGTGAACGTGGGAGTTCA GCTGCTTCTCTTGCCTAAGTATTCCTTTCCTGATCACTATGCATTTTAAAGTTAAACATTTTTAAGTATTTCAGATGCTTTAGAGAGATT TTTTTTCCATGACTGCATTTTACTGTACAGATTGCTGCTTCTGCTATATTTGTGATATAGGAATTAAGAGGATACACACGTTTGTTTCTT CGTGCCTGTTTTATGTGCACACATTAGGCATTGAGACTTCAAGCTTTTCTTTTTTTGTCCACGTATCTTTGGGTCTTTGATAAAGAAAAG AATCCCTGTTCATTGTAAGCACTTTTACGGGGCGGGTGGGGAGGGGTGCTCTGCTGGTCTTCAATTACCAAGAATTCTCCAAAACAATTT TCTGCAGGATGATTGTACAGAATCATTGCTTATGACATGATCGCTTTCTACACTGTATTACATAAATAAATTAAATAAAATAACCCCGGG CAAGACTTTTCTTTGAAGGATGACTACAGACATTAAATAATCGAAGTAATTTTGGGTGGGGAGAAGAGGCAGATTCAATTTTCTTTAACC AGTCTGAAGTTTCATTTATGATACAAAAGAAGATGAAAATGGAAGTGGCAATATAAGGGGATGAGGAAGGCATGCCTGGACAAACCCTTC TTTTAAGATGTGTCTTCAATTTGTATAAAATGGTGTTTTCATGTAAATAAATACATTCTTGGAGGAGCTTGGAAGTTCATGAGGCTAAGC CTGTGCCAGAAAATCACCCACAGTGGGATACAGCAATAGAGGGGGATGAAGACCAGGAGGACAGTGAGGGCTTTGAAGATAGCTTTGAGG AAGAAGAGGAGGAAGAAGAAGATGATGACTAAGCAGTACTCTGAATGGACCACAGTGTTTGCACATATTTGCAATTTTTTGCTGTTTTGG AAGTGTATCATAAACCAGAAACAGTACAGAACTGATGTTGAGGGAGGTGTAGTTTTTTTACTCTTGAAATGGGTGCATAATATAACTAGG CAGTGGCGGTGCCTTGGTACAACCTGAAAAATGTTAAGGCTTATTGAAACCTTTCAAGTAGGGGATGGTACATTTATTTCATCTGCAAAT GATAATAAATCCTTTGTTATTATAACTGTCCAGAAGTGTGGGCTATGTATTATCTGATCAGTCTATGGTCCCAGTAAAAGTAAAGATGCA GGAAACACAGTCTGTAAATGAGCGACTTTTCTTTGTTCAGCTTTAGTTTTAGCAAACACCACAAATATGTTTTAAGTAACATCGCTCAAG TTTAAGTAACATCGCTCAAGTTGATAATCTCTTGATAAGCTCTGTTGTTGACATTTTGCAGTGATACAACAGCTCCACTCATAGATTTAA ACTTTTATTTTTACTTATCTTGGTCATAAGTTGGCATTCTCTCACATTCCACATGATATAGAGGGCTACGTTTTGGAATTTTCCTTTTCT TAATTGCCCAGAGTTATCAGACAGATTATAAAAATGGCTTTTAATGGCTTAAACCATTTCTAAACCTCTATCTTAGCAGATCAATGCAGG ATCTAATTCTTTTGATAAGTTCTAGCTCTAAAAGTGATAGTGGGACTGTATGTTTTCTGATACTGGTGGCTTATGTTATTAAACCTTTTT TAAAAAAGGTTCACTCTAAAAGCTGAACTACATCCTTAGTTTTCAGTCTACTTGACTCTATCAGGAGCTTTTTAAGGAAAGTAAGTATAA CATGCAAAGGAAGCTTTTTTTGTATTCATTTTGGACTCCTGTCAATAAAAATAGAAGTTTGTTGACTCGTTTTATGTTTCAATGGTGTGT GTCTTTTTACTATCAGGACATAAATAGGGCAATCCACTTCTTTATTTTTCAACTAAAGATTGAATAGTATTGTACATTACTGCTAAAGTG ACTGCTATTTCTGTATACTGTAGAAAAACCCAGGAGTGAGAGGGATTTCCCCTCATAGTACAACTGGAAGGATAGTGCTTGTAAAGAGTA GAGATGTGTACATGATGAATCATTGAGGGAGGGTGGATATTTTTATTCCTAGATATGGAGGAAACATAAGTCTGTAGTATTATAAAACTG ATTGTAATAATTCTTTCCTATCAAAATCTCCATAGGTCAAAATATTGTTGGAATACTAAAATTTGCAACCTTGTTTACTTTAAAAGGTTG CCACTTTCAGTGCAGAATACTACCGGCATCTTGTTACTGCAATAGTTGGAAATAAAATGTGAAAATTAGCAAAACCATGAATGGTTTTTT TGGTTCTAAATTTAAGATGTAATATTTCCTATAAAAGGGTGAAAGCAGTTTCTTTCTCTATAACCTCAATCACCAGTTTAGTGAGAGCCT TTCTTGGCAGGCAGGAGGCAGTGTCACTGAGGATTTTTTTCATTTACTTCATTGTACAAGTAGGAGGGTGGGTTTAATTTTCAAATCAGG TTCTGCTGTGAAGCACCAGTGTCTTGAGGCAGCTACTGATTACCTAAGTGTGGTGGCAGGGGGTAAGCCAGCTGGTGTCAAGTGAAAGGA GGGATTAGAGAAAACAGGTGTGGCACGAAGGCAAGGAAACTGAGCAGACAAGACAGAACAATGTGTAGAATGCATATTTCCTAGTTTTCT TGAAAGATTTCAAGAAAAGTTGTTTTTTTTTTTCTAGTGGCTACTTTGCCTTAAAGAGGCTTTATAAGTTCATTCACACAGCTGGCTTCT CTGGTTTTAAGATTCTGGAGAGGATGATAACCTAGTAACACCACAGTGCTTAAAAAAAAAAAAAAAAAAAAAACTACCATCACCAGAAAA TTCCACCAGTTTGTTTTCCTTTTCTCTTTGTGTGATGTGTATGTACTTCCCAACTAAGTAAAATAAAATTTCCTCTAGTGAGTGCTTTAG GTAACCTCTTTCCATATGGCAGTAGTGAAAGAACTGAGCCTTCAGTTGATAGTTCTTCTCTCTCCAGCAAGTCGCTAAACTCCACATCCC TTCGTTTTTCCTCTGGAATGAGAATAACAAACTATCCTAGTTTGCATTTAATCTAATGGAAACTTGAGCAAAGTTTCAATTTTCTTCCTA TAAAGAAACTGACATTTTGTCAACAATTGATGAGCCTATAGATCATACAGTGTATAGGAAGTGAAATTGAAACAGTTAAATTATGTGATA TTTTTCTCTAATTGGTAAAGTACCTATTAAAATACAGCTGTTCATGAGGAGACTTACCACAATTCAAAGTGTAGCAGTTGTGTATTTTAG CATTATAATATTTGATTGAGGCCCTGAGGTGTTAATATCTCAATCTCAGAGTTAGATGTTCATGTCCTTTTTGAATTTTTTAAACATTTT TCATAATTTTTTTTTTAAGTTAGGGAGCACATTGAGTGAAGTTCTCTGTGTAGAACAATACCTTCTGCTCTGCTTCTCCCAGCTTTCACT GAGGGCTGGAAAAGGACAGGCCTGTCCAGCTGTACTGTCCCACTGTGTATGGGGAAGCTCAGGCTCTGGTGGAAGCAGGGGGCGTGGATG TCAAACAACTGATGTGGAAACAGGGAGGGAGAGATATAATGAGGCTCTCTAGGCATGTTATTTTTGACCACAAGTTTTGTTCAGTTTGCT TCAGCCAATCCAAACCATATACTAGAGTGTTCTGTAGTCACAATTCTTATTTCAAATGTAATTCAGCACCTTACATAATTTTTGAGAGGT TGTCATTCATCACATATTTACTGAGTTTCTATGTGCCAGGCTCTGTGACTGGATACTGGAGCTATCAAAATGAAAAAAATAGTGTTAAGA ACTCACTCGCTGGTGTTAGAGCAGGTAGATGAGTGGCAATCCATTTAAATCCATTTGCCTTGGCTATTATTTGGAATGCCTTTTTTTTTT TTTAGTCTATCTACTGTAGGCAGAAGAATTATTTCTTTAGGGGCTAGCTGTTTATTTTGCTGGCCTTTTTTTCTCTCTTTCTCTTTTTCT TCTTAAGACGGAGTCTCGCTCTGTCCTCCAGGCTGGAGGAGTGCAGTGGCACGATCTCAGCTCACTGCAACCTCCGCCTCCCAGCTTCAA GCGATTCTTCTGCCTCAGCCTCCTGAGTAGCTGGGACTGCAGGTGCATGCCACCACACCCAGCTAATTTTTTAATTTTTAGTAGAGATGG GATTTTGCCACGTTGTCCAGCCTGGTCTCGAACTCCTGGCCTCAAGTGATCAGCCCTCCTCAGCCTCCCAAAGTGCTGGCATTACAGGCA TGAGCCACTGCGCCCAGCCTGTTGGGTTTTTTTGGAAAAAAAACAAAAACAACAAATCATCATCCTTTCCTTTAAAATGTTTTTTTTTTT TTAAGAAACAATTTTCCCACAAACGGTCTGATTTAACTCCATGAAATCCTCTATTTAGACTGCCTTAAAGTGAAATAACTGTTGGTGAAC CATAACATTTTGCCAGCTGTGTAGTGATTAGTCCAAATATGTCTCAAGAAGTTAGCACCAAGCATTCTCATCCATTTAAACTTGATGCTA GGGCTATTTTGCAAAACTTAAAAAGATGCGATCTTGTACATATTTCTGTAACCTGAGCTGAAAACCCAAATAACAATCATTGACATACTT TAGGGCTATTGTTTCAGGTGGGGGTGTATACATCCCAGGGGCGTGGAGATGATCAATCCATTGAGGAAGTATTAAGATGATTATTTGTAT TTAATCTCATCCTTTTAAATTTCTATTTTTGTGTGTTTTATAATGTACATAATATATTGTACAATTGTACACTTCTATTATTTATAAATA AACATTTATTGGTGCATTAAGTAGAGCTGAAGTTTCCTGCACCAGGCAAGCCTGGAAATTATCAGTATACTGTGTTTCTGAGATCAGACT CCTATATGGGTTTGGATCAGATTAAACCATTGAAGGAAAAACAAGAATGGTGGTGGCTTTACATTGCAGATAGGAAGGAGCAGACATTAA TATCCATGCCATATCATGTGTGTACGCTGAAAGATACAGAGGAGGAGTGGCAAGAATTACAACAAAGCATACAGCGAAAAGAGAGAGCTC TATTGGAAACCAAATCAAAAATAACACATCCTGTGTATAGCCTTTACTTTCCTGAGGAAGCTGCAGTAAAGGAAGATGAAGAAGAAGTTT CAGATAAGGGCAGTGATTCTGAAGAAGAAGAAACCAATAGAGATTCCCAAAGTGAGAAAGATGATGGTAGTGACAGAGACTCTGATAGAG AGCAAGATGAAAAACAAAACAAAGATGATGAAGCAAAAAAAAAAGAAACCTTTAAAAAAAAAACCTACACCTGTGCTATTACCACAGTCA >5705_5705_1_APP-SEC63_APP_chr21_27252862_ENST00000358918_SEC63_chr6_108214782_ENST00000369002_length(amino acids)=752AA_BP= MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQ PVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFR GVEFVCCPLAEESDNVDSADAEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEEEADDDEDDEDGDEVEEEAEEPYEEATERTT SIATTTTTTTESVEEVVREVCSEQAETGPCRAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCGSAMSQSLLKTTQEPLARD PVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANER QQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYER MNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTETKTTVELLPVNGEFSLDDLQPWHSFGADSVP ANTENEGSGLTNIKTEEISEVKMDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKKQYTSIHHGVVEV -------------------------------------------------------------- >5705_5705_2_APP-SEC63_APP_chr21_27252862_ENST00000359726_SEC63_chr6_108214782_ENST00000369002_length(transcript)=8118nt_BP=3464nt GGATCAGCTGACTCGCCTGGCTCTGAGCCCCGCCGCCGCGCTCGGGCTCCGTCAGTTTCCTCGGCAGCGGTAGGCGAGAGCACGCGGAGG AGCGTGCGCGGGGGCCCCGGGAGACGGCGGCGGTGGCGGCGCGGGCAGAGCAAGGACGCGGCGGATCCCACTCGCACAGCAGCGCACTCG GTGCCCCGCGCAGGGTCGCGATGCTGCCCGGTTTGGCACTGCTCCTGCTGGCCGCCTGGACGGCTCGGGCGCTGGAGGTACCCACTGATG GTAATGCTGGCCTGCTGGCTGAACCCCAGATTGCCATGTTCTGTGGCAGACTGAACATGCACATGAATGTCCAGAATGGGAAGTGGGATT CAGATCCATCAGGGACCAAAACCTGCATTGATACCAAGGAAGGCATCCTGCAGTATTGCCAAGAAGTCTACCCTGAACTGCAGATCACCA ATGTGGTAGAAGCCAACCAACCAGTGACCATCCAGAACTGGTGCAAGCGGGGCCGCAAGCAGTGCAAGACCCATCCCCACTTTGTGATTC CCTACCGCTGCTTAGTTGGTGAGTTTGTAAGTGATGCCCTTCTCGTTCCTGACAAGTGCAAATTCTTACACCAGGAGAGGATGGATGTTT GCGAAACTCATCTTCACTGGCACACCGTCGCCAAAGAGACATGCAGTGAGAAGAGTACCAACTTGCATGACTACGGCATGTTGCTGCCCT GCGGAATTGACAAGTTCCGAGGGGTAGAGTTTGTGTGTTGCCCACTGGCTGAAGAAAGTGACAATGTGGATTCTGCTGATGCGGAGGAGG ATGACTCGGATGTCTGGTGGGGCGGAGCAGACACAGACTATGCAGATGGGAGTGAAGACAAAGTAGTAGAAGTAGCAGAGGAGGAAGAAG TGGCTGAGGTGGAAGAAGAAGAAGCCGATGATGACGAGGACGATGAGGATGGTGATGAGGTAGAGGAAGAGGCTGAGGAACCCTACGAAG AAGCCACAGAGAGAACCACCAGCATTGCCACCACCACCACCACCACCACAGAGTCTGTGGAAGAGGTGGTTCGAGTGTCCCAAAGTTTAC TCAAGACTACCCAGGAACCTCTTGCCCGAGATCCTGTTAAACTTCCTACAACAGCAGCCAGTACCCCTGATGCCGTTGACAAGTATCTCG AGACACCTGGGGATGAGAATGAACATGCCCATTTCCAGAAAGCCAAAGAGAGGCTTGAGGCCAAGCACCGAGAGAGAATGTCCCAGGTCA TGAGAGAATGGGAAGAGGCAGAACGTCAAGCAAAGAACTTGCCTAAAGCTGATAAGAAGGCAGTTATCCAGCATTTCCAGGAGAAAGTGG AATCTTTGGAACAGGAAGCAGCCAACGAGAGACAGCAGCTGGTGGAGACACACATGGCCAGAGTGGAAGCCATGCTCAATGACCGCCGCC GCCTGGCCCTGGAGAACTACATCACCGCTCTGCAGGCTGTTCCTCCTCGGCCTCGTCACGTGTTCAATATGCTAAAGAAGTATGTCCGCG CAGAACAGAAGGACAGACAGCACACCCTAAAGCATTTCGAGCATGTGCGCATGGTGGATCCCAAGAAAGCCGCTCAGATCCGGTCCCAGG TTATGACACACCTCCGTGTGATTTATGAGCGCATGAATCAGTCTCTCTCCCTGCTCTACAACGTGCCTGCAGTGGCCGAGGAGATTCAGG ATGAAGTTGATGAGCTGCTTCAGAAAGAGCAAAACTATTCAGATGACGTCTTGGCCAACATGATTAGTGAACCAAGGATCAGTTACGGAA ACGATGCTCTCATGCCATCTTTGACCGAAACGAAAACCACCGTGGAGCTCCTTCCCGTGAATGGAGAGTTCAGCCTGGACGATCTCCAGC CGTGGCATTCTTTTGGGGCTGACTCTGTGCCAGCCAACACAGAAAACGAAGTTGAGCCTGTTGATGCCCGCCCTGCTGCCGACCGAGGAC TGACCACTCGACCAGGTTCTGGGTTGACAAATATCAAGACGGAGGAGATCTCTGAAGTGAAGATGGATGCAGAATTCCGACATGACTCAG GATATGAAGTTCATCATCAAAAATTGGTGTTCTTTGCAGAAGATGTGGGTTCAAACAAAGGTGCAATCATTGGACTCATGGTGGGCGGTG TTGTCATAGCGACAGTGATCGTCATCACCTTGGTGATGCTGAAGAAGAAACAGTACACATCCATTCATCATGGTGTGGTGGAGGTTGACG CCGCTGTCACCCCAGAGGAGCGCCACCTGTCCAAGATGCAGCAGAACGGCTACGAAAATCCAACCTACAAGTTCTTTGAGCAGATGCAGA ACTAGACCCCCGCCACAGCAGCCTCTGAAGTTGGACAGCAAAACCATTGCTTCACTACCCATCGGTGTCCATTTATAGAATAATGTGGGA AGAAACAAACCCGTTTTATGATTTACTCATTATCGCCTTTTGACAGCTGTGCTGTAACACAAGTAGATGCCTGAACTTGAATTAATCCAC ACATCAGTAATGTATTCTATCTCTCTTTACATTTTGGTCTCTATACTACATTATTAATGGGTTTTGTGTACTGTAAAGAATTTAGCTGTA TCAAACTAGTGCATGAATAGATTCTCTCCTGATTATTTATCACATAGCCCCTTAGCCAGTTGTATATTATTCTTGTGGTTTGTGACCCAA TTAAGTCCTACTTTACATATGCTTTAAGAATCGATGGGGGATGCTTCATGTGAACGTGGGAGTTCAGCTGCTTCTCTTGCCTAAGTATTC CTTTCCTGATCACTATGCATTTTAAAGTTAAACATTTTTAAGTATTTCAGATGCTTTAGAGAGATTTTTTTTCCATGACTGCATTTTACT GTACAGATTGCTGCTTCTGCTATATTTGTGATATAGGAATTAAGAGGATACACACGTTTGTTTCTTCGTGCCTGTTTTATGTGCACACAT TAGGCATTGAGACTTCAAGCTTTTCTTTTTTTGTCCACGTATCTTTGGGTCTTTGATAAAGAAAAGAATCCCTGTTCATTGTAAGCACTT TTACGGGGCGGGTGGGGAGGGGTGCTCTGCTGGTCTTCAATTACCAAGAATTCTCCAAAACAATTTTCTGCAGGATGATTGTACAGAATC ATTGCTTATGACATGATCGCTTTCTACACTGTATTACATAAATAAATTAAATAAAATAACCCCGGGCAAGACTTTTCTTTGAAGGATGAC TACAGACATTAAATAATCGAAGTAATTTTGGGTGGGGAGAAGAGGCAGATTCAATTTTCTTTAACCAGTCTGAAGTTTCATTTATGATAC AAAAGAAGATGAAAATGGAAGTGGCAATATAAGGGGATGAGGAAGGCATGCCTGGACAAACCCTTCTTTTAAGATGTGTCTTCAATTTGT ATAAAATGGTGTTTTCATGTAAATAAATACATTCTTGGAGGAGCTTGGAAGTTCATGAGGCTAAGCCTGTGCCAGAAAATCACCCACAGT GGGATACAGCAATAGAGGGGGATGAAGACCAGGAGGACAGTGAGGGCTTTGAAGATAGCTTTGAGGAAGAAGAGGAGGAAGAAGAAGATG ATGACTAAGCAGTACTCTGAATGGACCACAGTGTTTGCACATATTTGCAATTTTTTGCTGTTTTGGAAGTGTATCATAAACCAGAAACAG TACAGAACTGATGTTGAGGGAGGTGTAGTTTTTTTACTCTTGAAATGGGTGCATAATATAACTAGGCAGTGGCGGTGCCTTGGTACAACC TGAAAAATGTTAAGGCTTATTGAAACCTTTCAAGTAGGGGATGGTACATTTATTTCATCTGCAAATGATAATAAATCCTTTGTTATTATA ACTGTCCAGAAGTGTGGGCTATGTATTATCTGATCAGTCTATGGTCCCAGTAAAAGTAAAGATGCAGGAAACACAGTCTGTAAATGAGCG ACTTTTCTTTGTTCAGCTTTAGTTTTAGCAAACACCACAAATATGTTTTAAGTAACATCGCTCAAGTTTAAGTAACATCGCTCAAGTTGA TAATCTCTTGATAAGCTCTGTTGTTGACATTTTGCAGTGATACAACAGCTCCACTCATAGATTTAAACTTTTATTTTTACTTATCTTGGT CATAAGTTGGCATTCTCTCACATTCCACATGATATAGAGGGCTACGTTTTGGAATTTTCCTTTTCTTAATTGCCCAGAGTTATCAGACAG ATTATAAAAATGGCTTTTAATGGCTTAAACCATTTCTAAACCTCTATCTTAGCAGATCAATGCAGGATCTAATTCTTTTGATAAGTTCTA GCTCTAAAAGTGATAGTGGGACTGTATGTTTTCTGATACTGGTGGCTTATGTTATTAAACCTTTTTTAAAAAAGGTTCACTCTAAAAGCT GAACTACATCCTTAGTTTTCAGTCTACTTGACTCTATCAGGAGCTTTTTAAGGAAAGTAAGTATAACATGCAAAGGAAGCTTTTTTTGTA TTCATTTTGGACTCCTGTCAATAAAAATAGAAGTTTGTTGACTCGTTTTATGTTTCAATGGTGTGTGTCTTTTTACTATCAGGACATAAA TAGGGCAATCCACTTCTTTATTTTTCAACTAAAGATTGAATAGTATTGTACATTACTGCTAAAGTGACTGCTATTTCTGTATACTGTAGA AAAACCCAGGAGTGAGAGGGATTTCCCCTCATAGTACAACTGGAAGGATAGTGCTTGTAAAGAGTAGAGATGTGTACATGATGAATCATT GAGGGAGGGTGGATATTTTTATTCCTAGATATGGAGGAAACATAAGTCTGTAGTATTATAAAACTGATTGTAATAATTCTTTCCTATCAA AATCTCCATAGGTCAAAATATTGTTGGAATACTAAAATTTGCAACCTTGTTTACTTTAAAAGGTTGCCACTTTCAGTGCAGAATACTACC GGCATCTTGTTACTGCAATAGTTGGAAATAAAATGTGAAAATTAGCAAAACCATGAATGGTTTTTTTGGTTCTAAATTTAAGATGTAATA TTTCCTATAAAAGGGTGAAAGCAGTTTCTTTCTCTATAACCTCAATCACCAGTTTAGTGAGAGCCTTTCTTGGCAGGCAGGAGGCAGTGT CACTGAGGATTTTTTTCATTTACTTCATTGTACAAGTAGGAGGGTGGGTTTAATTTTCAAATCAGGTTCTGCTGTGAAGCACCAGTGTCT TGAGGCAGCTACTGATTACCTAAGTGTGGTGGCAGGGGGTAAGCCAGCTGGTGTCAAGTGAAAGGAGGGATTAGAGAAAACAGGTGTGGC ACGAAGGCAAGGAAACTGAGCAGACAAGACAGAACAATGTGTAGAATGCATATTTCCTAGTTTTCTTGAAAGATTTCAAGAAAAGTTGTT TTTTTTTTTCTAGTGGCTACTTTGCCTTAAAGAGGCTTTATAAGTTCATTCACACAGCTGGCTTCTCTGGTTTTAAGATTCTGGAGAGGA TGATAACCTAGTAACACCACAGTGCTTAAAAAAAAAAAAAAAAAAAAAACTACCATCACCAGAAAATTCCACCAGTTTGTTTTCCTTTTC TCTTTGTGTGATGTGTATGTACTTCCCAACTAAGTAAAATAAAATTTCCTCTAGTGAGTGCTTTAGGTAACCTCTTTCCATATGGCAGTA GTGAAAGAACTGAGCCTTCAGTTGATAGTTCTTCTCTCTCCAGCAAGTCGCTAAACTCCACATCCCTTCGTTTTTCCTCTGGAATGAGAA TAACAAACTATCCTAGTTTGCATTTAATCTAATGGAAACTTGAGCAAAGTTTCAATTTTCTTCCTATAAAGAAACTGACATTTTGTCAAC AATTGATGAGCCTATAGATCATACAGTGTATAGGAAGTGAAATTGAAACAGTTAAATTATGTGATATTTTTCTCTAATTGGTAAAGTACC TATTAAAATACAGCTGTTCATGAGGAGACTTACCACAATTCAAAGTGTAGCAGTTGTGTATTTTAGCATTATAATATTTGATTGAGGCCC TGAGGTGTTAATATCTCAATCTCAGAGTTAGATGTTCATGTCCTTTTTGAATTTTTTAAACATTTTTCATAATTTTTTTTTTAAGTTAGG GAGCACATTGAGTGAAGTTCTCTGTGTAGAACAATACCTTCTGCTCTGCTTCTCCCAGCTTTCACTGAGGGCTGGAAAAGGACAGGCCTG TCCAGCTGTACTGTCCCACTGTGTATGGGGAAGCTCAGGCTCTGGTGGAAGCAGGGGGCGTGGATGTCAAACAACTGATGTGGAAACAGG GAGGGAGAGATATAATGAGGCTCTCTAGGCATGTTATTTTTGACCACAAGTTTTGTTCAGTTTGCTTCAGCCAATCCAAACCATATACTA GAGTGTTCTGTAGTCACAATTCTTATTTCAAATGTAATTCAGCACCTTACATAATTTTTGAGAGGTTGTCATTCATCACATATTTACTGA GTTTCTATGTGCCAGGCTCTGTGACTGGATACTGGAGCTATCAAAATGAAAAAAATAGTGTTAAGAACTCACTCGCTGGTGTTAGAGCAG GTAGATGAGTGGCAATCCATTTAAATCCATTTGCCTTGGCTATTATTTGGAATGCCTTTTTTTTTTTTTAGTCTATCTACTGTAGGCAGA AGAATTATTTCTTTAGGGGCTAGCTGTTTATTTTGCTGGCCTTTTTTTCTCTCTTTCTCTTTTTCTTCTTAAGACGGAGTCTCGCTCTGT CCTCCAGGCTGGAGGAGTGCAGTGGCACGATCTCAGCTCACTGCAACCTCCGCCTCCCAGCTTCAAGCGATTCTTCTGCCTCAGCCTCCT GAGTAGCTGGGACTGCAGGTGCATGCCACCACACCCAGCTAATTTTTTAATTTTTAGTAGAGATGGGATTTTGCCACGTTGTCCAGCCTG GTCTCGAACTCCTGGCCTCAAGTGATCAGCCCTCCTCAGCCTCCCAAAGTGCTGGCATTACAGGCATGAGCCACTGCGCCCAGCCTGTTG GGTTTTTTTGGAAAAAAAACAAAAACAACAAATCATCATCCTTTCCTTTAAAATGTTTTTTTTTTTTTAAGAAACAATTTTCCCACAAAC GGTCTGATTTAACTCCATGAAATCCTCTATTTAGACTGCCTTAAAGTGAAATAACTGTTGGTGAACCATAACATTTTGCCAGCTGTGTAG TGATTAGTCCAAATATGTCTCAAGAAGTTAGCACCAAGCATTCTCATCCATTTAAACTTGATGCTAGGGCTATTTTGCAAAACTTAAAAA GATGCGATCTTGTACATATTTCTGTAACCTGAGCTGAAAACCCAAATAACAATCATTGACATACTTTAGGGCTATTGTTTCAGGTGGGGG TGTATACATCCCAGGGGCGTGGAGATGATCAATCCATTGAGGAAGTATTAAGATGATTATTTGTATTTAATCTCATCCTTTTAAATTTCT ATTTTTGTGTGTTTTATAATGTACATAATATATTGTACAATTGTACACTTCTATTATTTATAAATAAACATTTATTGGTGCATTAAGTAG AGCTGAAGTTTCCTGCACCAGGCAAGCCTGGAAATTATCAGTATACTGTGTTTCTGAGATCAGACTCCTATATGGGTTTGGATCAGATTA AACCATTGAAGGAAAAACAAGAATGGTGGTGGCTTTACATTGCAGATAGGAAGGAGCAGACATTAATATCCATGCCATATCATGTGTGTA CGCTGAAAGATACAGAGGAGGAGTGGCAAGAATTACAACAAAGCATACAGCGAAAAGAGAGAGCTCTATTGGAAACCAAATCAAAAATAA CACATCCTGTGTATAGCCTTTACTTTCCTGAGGAAGCTGCAGTAAAGGAAGATGAAGAAGAAGTTTCAGATAAGGGCAGTGATTCTGAAG AAGAAGAAACCAATAGAGATTCCCAAAGTGAGAAAGATGATGGTAGTGACAGAGACTCTGATAGAGAGCAAGATGAAAAACAAAACAAAG ATGATGAAGCAAAAAAAAAAGAAACCTTTAAAAAAAAAACCTACACCTGTGCTATTACCACAGTCAAAGCAACAGAAACAAAAGCAGGCA >5705_5705_2_APP-SEC63_APP_chr21_27252862_ENST00000359726_SEC63_chr6_108214782_ENST00000369002_length(amino acids)=714AA_BP= MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQ PVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFR GVEFVCCPLAEESDNVDSADAEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEEEADDDEDDEDGDEVEEEAEEPYEEATERTT SIATTTTTTTESVEEVVRVSQSLLKTTQEPLARDPVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEA ERQAKNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRAEQKDRQ HTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPS LTETKTTVELLPVNGEFSLDDLQPWHSFGADSVPANTENEVEPVDARPAADRGLTTRPGSGLTNIKTEEISEVKMDAEFRHDSGYEVHHQ -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for APP-SEC63 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 732_751 | 1144.3333333333333 | 771.0 | G(o)-alpha |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 732_751 | 1069.3333333333333 | 696.0 | G(o)-alpha |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 732_751 | 1013.3333333333334 | 640.0 | G(o)-alpha |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 732_751 | 1125.3333333333333 | 752.0 | G(o)-alpha |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 732_751 | 1126.0 | 753.0 | G(o)-alpha |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 732_751 | 1088.0 | 715.0 | G(o)-alpha |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000346798 | - | 18 | 18 | 695_722 | 1144.3333333333333 | 771.0 | PSEN1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000348990 | - | 16 | 16 | 695_722 | 1069.3333333333333 | 696.0 | PSEN1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000354192 | - | 15 | 15 | 695_722 | 1013.3333333333334 | 640.0 | PSEN1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000357903 | - | 17 | 17 | 695_722 | 1125.3333333333333 | 752.0 | PSEN1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000358918 | - | 17 | 17 | 695_722 | 1126.0 | 753.0 | PSEN1 |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000359726 | - | 17 | 17 | 695_722 | 1088.0 | 715.0 | PSEN1 |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 732_751 | 0 | 747.0 | G(o)-alpha |
Hgene | APP | chr21:27252862 | chr6:108214782 | ENST00000440126 | - | 1 | 17 | 695_722 | 0 | 747.0 | PSEN1 |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for APP-SEC63 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for APP-SEC63 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | APP | C0002395 | Alzheimer's Disease | 63 | CTD_human;UNIPROT |
Hgene | APP | C0011265 | Presenile dementia | 35 | CTD_human |
Hgene | APP | C0276496 | Familial Alzheimer Disease (FAD) | 35 | CTD_human |
Hgene | APP | C0494463 | Alzheimer Disease, Late Onset | 35 | CTD_human |
Hgene | APP | C0546126 | Acute Confusional Senile Dementia | 35 | CTD_human |
Hgene | APP | C0750900 | Alzheimer's Disease, Focal Onset | 35 | CTD_human |
Hgene | APP | C0750901 | Alzheimer Disease, Early Onset | 35 | CTD_human |
Hgene | APP | C0025261 | Memory Disorders | 16 | CTD_human |
Hgene | APP | C0233794 | Memory impairment | 16 | CTD_human |
Hgene | APP | C0751292 | Age-Related Memory Disorders | 16 | CTD_human |
Hgene | APP | C0751293 | Memory Disorder, Semantic | 16 | CTD_human |
Hgene | APP | C0751294 | Memory Disorder, Spatial | 16 | CTD_human |
Hgene | APP | C0751295 | Memory Loss | 16 | CTD_human |
Hgene | APP | C0027746 | Nerve Degeneration | 11 | CTD_human |
Hgene | APP | C0023186 | Learning Disorders | 8 | CTD_human |
Hgene | APP | C0751262 | Adult Learning Disorders | 8 | CTD_human |
Hgene | APP | C0751263 | Learning Disturbance | 8 | CTD_human |
Hgene | APP | C0751265 | Learning Disabilities | 8 | CTD_human |
Hgene | APP | C1330966 | Developmental Academic Disorder | 8 | CTD_human |
Hgene | APP | C2751536 | CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED | 7 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | APP | C0009241 | Cognition Disorders | 5 | CTD_human |
Hgene | APP | C0011570 | Mental Depression | 5 | PSYGENET |
Hgene | APP | C0011581 | Depressive disorder | 5 | PSYGENET |
Hgene | APP | C0234544 | Todd Paralysis | 5 | CTD_human |
Hgene | APP | C0522224 | Paralysed | 5 | CTD_human |
Hgene | APP | C0497327 | Dementia | 3 | CTD_human;GENOMICS_ENGLAND |
Hgene | APP | C2931672 | Cerebral hemorrhage with amyloidosis, hereditary, Dutch type | 3 | CTD_human;ORPHANET |
Hgene | APP | C0270715 | Degenerative Diseases, Central Nervous System | 2 | CTD_human |
Hgene | APP | C0333463 | Senile Plaques | 2 | CTD_human |
Hgene | APP | C0524851 | Neurodegenerative Disorders | 2 | CTD_human |
Hgene | APP | C0600467 | Neurogenic Inflammation | 2 | CTD_human |
Hgene | APP | C0751733 | Degenerative Diseases, Spinal Cord | 2 | CTD_human |
Hgene | APP | C2751494 | CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT | 2 | CTD_human |
Hgene | APP | C2936349 | Plaque, Amyloid | 2 | CTD_human |
Hgene | APP | C3888307 | CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT | 2 | CTD_human |
Hgene | APP | C3888308 | CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT | 2 | CTD_human |
Hgene | APP | C3888309 | CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT | 2 | CTD_human |
Hgene | APP | C0002622 | Amnesia | 1 | CTD_human |
Hgene | APP | C0002726 | Amyloidosis | 1 | CTD_human |
Hgene | APP | C0003469 | Anxiety Disorders | 1 | CTD_human |
Hgene | APP | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Hgene | APP | C0006111 | Brain Diseases | 1 | CTD_human |
Hgene | APP | C0011573 | Endogenous depression | 1 | PSYGENET |
Hgene | APP | C0016667 | Fragile X Syndrome | 1 | CTD_human |
Hgene | APP | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | APP | C0027540 | Necrosis | 1 | CTD_human |
Hgene | APP | C0033141 | Cardiomyopathies, Primary | 1 | CTD_human |
Hgene | APP | C0036529 | Myocardial Diseases, Secondary | 1 | CTD_human |
Hgene | APP | C0036572 | Seizures | 1 | GENOMICS_ENGLAND |
Hgene | APP | C0037928 | Spinal Cord Diseases | 1 | CTD_human |
Hgene | APP | C0038002 | Splenomegaly | 1 | CTD_human |
Hgene | APP | C0038454 | Cerebrovascular accident | 1 | GENOMICS_ENGLAND |
Hgene | APP | C0043094 | Weight Gain | 1 | CTD_human |
Hgene | APP | C0085220 | Cerebral Amyloid Angiopathy | 1 | CTD_human |
Hgene | APP | C0085584 | Encephalopathies | 1 | CTD_human |
Hgene | APP | C0231341 | Premature aging syndrome | 1 | CTD_human |
Hgene | APP | C0233750 | Hysterical amnesia | 1 | CTD_human |
Hgene | APP | C0233796 | Temporary Amnesia | 1 | CTD_human |
Hgene | APP | C0234985 | Mental deterioration | 1 | CTD_human |
Hgene | APP | C0236795 | Dissociative Amnesia | 1 | CTD_human |
Hgene | APP | C0262497 | Global Amnesia | 1 | CTD_human |
Hgene | APP | C0270612 | Leukoencephalopathy | 1 | GENOMICS_ENGLAND |
Hgene | APP | C0338582 | Sporadic Cerebral Amyloid Angiopathy | 1 | CTD_human |
Hgene | APP | C0338630 | Senile Paranoid Dementia | 1 | CTD_human |
Hgene | APP | C0338656 | Impaired cognition | 1 | CTD_human |
Hgene | APP | C0376280 | Anxiety States, Neurotic | 1 | CTD_human |
Hgene | APP | C0553692 | Brain hemorrhage | 1 | GENOMICS_ENGLAND |
Hgene | APP | C0750906 | Tactile Amnesia | 1 | CTD_human |
Hgene | APP | C0750907 | Amnestic State | 1 | CTD_human |
Hgene | APP | C0751071 | Familial Dementia | 1 | CTD_human |
Hgene | APP | C0751156 | FRAXA Syndrome | 1 | CTD_human |
Hgene | APP | C0751157 | FRAXE Syndrome | 1 | CTD_human |
Hgene | APP | C0878544 | Cardiomyopathies | 1 | CTD_human |
Hgene | APP | C0948008 | Ischemic stroke | 1 | GENOMICS_ENGLAND |
Hgene | APP | C1270972 | Mild cognitive disorder | 1 | CTD_human |
Hgene | APP | C1279420 | Anxiety neurosis (finding) | 1 | CTD_human |
Tgene | C0158683 | Polycystic liver disease | 2 | CTD_human;ORPHANET | |
Tgene | C0022680 | Polycystic Kidney Diseases | 1 | CTD_human | |
Tgene | C1567435 | Polycystic Kidney - body part | 1 | CTD_human | |
Tgene | C4310769 | POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS | 1 | GENOMICS_ENGLAND |